-
1 Comment
Medical Developments International Limited is currently in a long term downtrend where the price is trading 23.3% below its 200 day moving average.
From a valuation standpoint, the stock is 94.3% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 14.7.
Medical Developments International Limited's total revenue rose by 13.3% to $13M since the same quarter in the previous year.
Its net income has dropped by 573.8% to $-1M since the same quarter in the previous year.
Finally, its free cash flow grew by 41.7% to $-2M since the same quarter in the previous year.
Based on the above factors, Medical Developments International Limited gets an overall score of 3/5.
Industry | Drug Manufacturers - Specialty & Generic |
---|---|
Exchange | AU |
CurrencyCode | AUD |
ISIN | AU000000MVP2 |
Sector | Healthcare |
PE Ratio | None |
---|---|
Market Cap | 72M |
Target Price | 2.31 |
Beta | 1.48 |
Dividend Yield | None |
Medical Developments International Limited manufactures and distributes emergency medical solutions in Australia, Europe, the United States, and internationally. The company operates through Pain Management and Respiratory segments. It offers Penthrox, a trauma and emergency pain relief product for use in hospitals, emergency departments, ambulance services, sport medicines, and for analgesia during short procedures. The company also distributes asthma and chronic obstructive pulmonary disease products, such space chambers, peak flow meters, portable nebulisers, and silicon face mask. The company was founded in 1972 and is headquartered in Scoresby, Australia.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for MVP.AU using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025